Skip to main content
Optimi Health Corp. logo

Optimi Health Corp. — Investor Relations & Filings

Ticker · OPTI ISIN · CA68405H1001 LEI · 98450063FDFF8UD3Q652 CSE Manufacturing
Filings indexed 276 across all filing types
Latest filing 2026-02-26 Regulatory Filings
Country CA Canada
Listing CSE OPTI

About Optimi Health Corp.

https://www.optimihealth.ca/

Optimi Health Corp. is a GMP-certified pharmaceutical drug manufacturer and end-to-end drug researcher licensed to produce and supply controlled psychedelic substances. The company specializes in the production of MDMA and psilocybin, primarily supporting psychedelic-based mental health treatments. Additionally, Optimi operates a vertically integrated functional mushroom brand, developing scalable, natural mushroom formulations aimed at the health and wellness sector. This structure allows the company to serve both regulated pharmaceutical supply chains and consumer wellness markets.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2026-02-26 English
Optimi Health berichtet uber den fruhen klinischen Einsatz naturlicher Psilocybin-Kapseln zur Behandlung therapieresistenter Depressionen in Australien
Regulatory Filings Classification · 95% confidence The document is a corporate press release issued by Optimi Health Corp. regarding the clinical use of their psilocybin products in Australia. It follows the standard format of a corporate news announcement, including contact information, forward-looking statements, and distribution via a news service (EQS Group). It does not constitute a formal financial report (like a 10-K or IR), nor is it a report publication announcement (RPA) as it contains the full content of the news rather than just a link to a report. As it is a general corporate announcement regarding business operations and regulatory milestones, it falls under the 'Regulatory Filings' (RNS) category as the fallback for miscellaneous corporate news.
2026-02-26 German
News release - English.pdf
Regulatory Filings
2026-02-19 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2026-02-19 English
Interim MD&A - English.pdf
Regulatory Filings
2026-02-19 English
Interim financial statements/report – English.pdf
Regulatory Filings
2026-02-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.